Filing
Spy
Filing
Spy
Home
About
NBSE
Neubase Therapeutics Inc
Biotechnology company
CUSIP: 64132K201
Healthcare
US
1 holder
Ownership
Activity
2023 Q3
2 of 3 quarters
Total Value
$118.6K
Total Shares
136.3K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Greenlight Capital
$118.6K
136.3K
0.0%
Unchanged
Greenlight Capital
$118.6K
136.3K shares
Unchanged
NBSE — Neubase Therapeutics Inc - FilingSpy